Zymeworks (ZYME) Stock Statistics & Valuation Metrics

Zymeworks has a market cap or net worth of $882.38M. The enterprise value is $839.78M.

Zymeworks has 69,683,495 shares outstanding. The number of shares has decreased by -2.65% in one year.

Zymeworks’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -33.39%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Zymeworks had revenue of 76.30M and earned -122.69M in profits. Earnings per share was -1.62.

In the last 12 months, operating cash flow was -73.54M and capital expenditures 316.00K, giving a free cash flow of -78.08M billion.

Zymeworks pays an annual dividend of ―, resulting in a dividend yield of ―

Zymeworks upcoming earnings date is Aug 7, 2025, Before Open (Confirmed).

Zymeworks as a current ratio of 3.40, with Debt / Equity ratio of 5.68%

In the past 12 months, Zymeworks has paid 6.08M in taxes.

Zymeworks EV to EBITDA ratio is 441.24, with an EV/FCF ratio of 411.23.

Zymeworks has $265.29M in cash and marketable securities with $18.46M in debt, giving a net cash position of -$246.83M billion.

Gross margin is 90.49%, with operating margin of -157.03%, and net profit margin of -160.80%.

The average price target for Zymeworks is $23.80, which is 11.43% higher than the current price. The consensus rating is Strong Buy